Life Sciences Two People
NNIT Expectation Barometer 2023

Data enablement and digital business models

The potential of data enablement in life sciences

For companies in the life sciences industry, data is the most important asset to create better results throughout the value chain. By leveraging your data across the value chain, you can improve decision-making, efficiency, and quality and you can bring your products faster to market.

In the future, data is key to staying relevant and competitive – and ultimately bring better products to patients.   

But how do you bring data to live across different business units? How do you leverage  data to ensure cost savings, more efficiency and higher quality? And are you reaping the benefits of digitizing your business processes?  

Realizing your full data potential requires the right mix of technologies, skills, structures, and priorities.  

Where are you on the data journey?

Take the test and get 

  • Your overall score  
  • Your benchmark map  
  • Insight into where you stand out from the crowd 
  • Recommendations for going to the next level.  


We will of course also send you the overall results, spiced with in-dept analysis of the tendencies and concrete advice from NNIT’s experts.  

You will also get access to exclusive “behind the scenes” cases with digital leaders from global life sciences companies such as Novo Nordisk, Boehringer Ingelheim, Lonza, Ipsen and Lundbeck.

Want to learn more about the topic?

Read the article "Data enablement is the key to staying relevant and competitive in the life sciences industry" and learn more about the topic and why Data Enablement is the theme of NNIT Expectation Barometer 2023 here.

About NNIT Expectation Barometer  

Every year, NNIT conducts an Expectation Barometer. It is an online survey where we focus on digitalization and take the pulse of different digital themes in organizations, spiced with in-depth interviews and case stories with selected digital leaders.  

Last year, more than 500 respondents participated in the survey. In 2023, we will focus on data enablement and the enormous potential of utilizing data across the life sciences industry to improve quality and competitiveness – and ultimately bring better products to patients.